Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rhabdomyolysis in glutaric aciduria type I.

S L Chow1, C Rohan, A A M Morris

  • 1Metabolic Unit, Great Ormond Street Hospital, London.

Journal of Inherited Metabolic Disease
|January 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of 26 Gy in five fractions over 1 week adjuvant radiotherapy for breast cancer: Prospective report of acute skin toxicity and consideration of resource implications.

Breast (Edinburgh, Scotland)·2023
Same author

Homocystinuria patient and caregiver survey: experiences of diagnosis and patient satisfaction.

Orphanet journal of rare diseases·2021
Same author

Lathosterolosis: A Relatively Mild Case with Cataracts and Learning Difficulties.

JIMD reports·2018
Same author

Erratum to: Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.

JIMD reports·2016
Same author

Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.

JIMD reports·2016
Same author

Recurrent Ventricular Tachycardia in Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency.

JIMD reports·2015
Same journal

Biallelic Loss-Of-Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
See all related articles

Recurrent rhabdomyolysis, a muscle-wasting condition, may be specifically associated with glutaric aciduria type I. This finding is based on a second patient diagnosed with this rare metabolic disorder.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Glutaric aciduria type I (GA-I) is a rare inherited metabolic disorder.
  • It is caused by deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to accumulation of toxic metabolites.
  • Neurological complications, including dystonia and basal ganglia damage, are common in GA-I.

Observation:

  • Rhabdomyolysis, characterized by muscle breakdown and release of myoglobin, is a known but infrequent complication of metabolic disorders.
  • Recurrent rhabdomyolysis was previously documented in a single patient with GA-I.
  • This report details a second, unrelated patient experiencing recurrent rhabdomyolysis in the context of GA-I.

Findings:

  • The occurrence of rhabdomyolysis in two distinct GA-I patients suggests a potential specific association.

Related Experiment Videos

  • This association warrants further investigation into the underlying pathophysiological mechanisms linking GA-I and muscle injury.
  • Identifying this link could aid in early diagnosis and management of both conditions.

    • Implications:

    • Early recognition of rhabdomyolysis risk in GA-I patients may improve clinical outcomes.
    • Understanding this association could lead to targeted therapeutic strategies for preventing muscle damage in GA-I.
    • This finding highlights the importance of considering specific metabolic disorders in cases of recurrent unexplained rhabdomyolysis.